Terms: = Colorectal cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
38 results:
1. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
[No Abstract] [Full Text] [Related]
2. LINC00662 Promotes Aggressive Traits by Modulating oct4 Expression through miR-335-5p in Gallbladder cancer Cells.
Pérez-Moreno P; Riquelme I; Bizama C; Vergara-Gómez L; Tapia JC; Brebi P; García P; Roa JC
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928444
[TBL] [Abstract] [Full Text] [Related]
3. Metastases and treatment-resistant lineages in patient-derived cancer cells of colorectal cancer.
Fujino S; Miyoshi N; Ito A; Hayashi R; Yasui M; Matsuda C; Ohue M; Horie M; Yachida S; Koseki J; Shimamura T; Hata T; Ogino T; Takahashi H; Uemura M; Mizushima T; Doki Y; Eguchi H
Commun Biol; 2023 Nov; 6(1):1191. PubMed ID: 37996567
[TBL] [Abstract] [Full Text] [Related]
4. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
[TBL] [Abstract] [Full Text] [Related]
5. Modulation of rectal cancer stemness, patient outcome and therapy response by adipokines.
Marques V; Ourô S; Afonso MB; Rodrigues CMP
J Physiol Biochem; 2023 May; 79(2):261-272. PubMed ID: 36495464
[TBL] [Abstract] [Full Text] [Related]
6. FK866 inhibits colorectal cancer metastasis by reducing NAD
Xie H; Lei Y; Mao Y; Lan J; Yang J; Quan H; Zhang T
Genes Genomics; 2022 Dec; 44(12):1531-1541. PubMed ID: 36214983
[TBL] [Abstract] [Full Text] [Related]
7. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
[TBL] [Abstract] [Full Text] [Related]
8. miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer.
Li Y; Xun J; Wang B; Ma Y; Zhang L; Yang L; Gao R; Guan J; Liu T; Gao H; Wang X; Zhang Q
J Transl Med; 2021 Oct; 19(1):429. PubMed ID: 34656128
[TBL] [Abstract] [Full Text] [Related]
9. Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway.
Sánchez-Botet A; Quandt E; Masip N; Escribá R; Novellasdemunt L; Gasa L; Li VSW; Raya Á; Clotet J; Ribeiro MPC
Cell Oncol (Dordr); 2021 Dec; 44(6):1273-1286. PubMed ID: 34604945
[TBL] [Abstract] [Full Text] [Related]
10. High Expression of Stem Cell-Related Genes in Polyps with Villous Features and High-Grade Dysplasia Support Malignant Phenotype and colorectal Carcinogenesis.
Sahin I; Gündoğdu B; Ceylan AC; Erdem HB; Tatar A
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2429-2435. PubMed ID: 34452555
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA KLK8 modulates stem cell characteristics in colon cancer.
Wang K; Song W; Shen Y; Wang H; Fan Z
Pathol Res Pract; 2021 Aug; 224():153437. PubMed ID: 34271345
[TBL] [Abstract] [Full Text] [Related]
12. USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide.
Zhang S; Ju X; Yang Q; Zhu Y; Fan D; Su G; Kong L; Li Y
Biochem Biophys Res Commun; 2021 Jul; 562():21-28. PubMed ID: 34030041
[TBL] [Abstract] [Full Text] [Related]
13. A comprehensive assessment of the impact of a colorectal cancer screening program in a northern Italian area.
Pancheri S; Pertile R; Armelao F; Rizzello RV; Piffer S; Zorzi M; Guzzinati S; Ferro A; Mantovani W; de Pretis G
Dig Liver Dis; 2022 Mar; 54(3):400-406. PubMed ID: 33853757
[TBL] [Abstract] [Full Text] [Related]
14. Nicotine-derived NNK induces the stemness enrichment of CRC cells through regulating the balance of DUSP4-ERK1/2 feedback loop.
Chen Y; Wang Q; Cao L; Tang Y; Yao M; Bi H; Huang Y; Sun G; Song J
Ecotoxicol Environ Saf; 2021 May; 214():112057. PubMed ID: 33662786
[TBL] [Abstract] [Full Text] [Related]
15. Crenolanib Regulates ERK and AKT/mTOR Signaling Pathways in RAS/BRAF-Mutated colorectal cancer Cells and Organoids.
Fujino S; Miyoshi N; Ito A; Yasui M; Ohue M; Ogino T; Takahashi H; Uemura M; Matsuda C; Mizushima T; Doki Y; Eguchi H
Mol Cancer Res; 2021 May; 19(5):812-822. PubMed ID: 33579816
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of oct4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation.
Fang W; Ni M; Zhang M; Chen H
Biomark Med; 2020 Oct; 14(15):1473-1484. PubMed ID: 33185466
[No Abstract] [Full Text] [Related]
17. Prognostic implication of SOX2 expression in small intestinal adenocarcinoma.
Kim JW; Chung JY; Ylaya K; Park Y; Jun SY; Hong SM; Hewitt SM
Virchows Arch; 2021 Jun; 478(6):1049-1060. PubMed ID: 33103210
[TBL] [Abstract] [Full Text] [Related]
18.
Bhattacharya A; Mukherjee S; Khan P; Banerjee S; Dutta A; Banerjee N; Sengupta D; Basak U; Chakraborty S; Dutta A; Chattopadhyay S; Jana K; Sarkar DK; Chatterjee S; Das T
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082288
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
Zhao X; Lu H; Sun Y; Liu L; Wang H
Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
[TBL] [Abstract] [Full Text] [Related]
20. Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.
Arians N; Häfner M; Krisam J; Lang K; Wark A; Koerber SA; Hommertgen A; Debus J
BMC Cancer; 2020 Jan; 20(1):52. PubMed ID: 31964381
[TBL] [Abstract] [Full Text] [Related]
[Next]
